338 related articles for article (PubMed ID: 24355310)
1. Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation.
Qureshi W; Mittal C; Patsias I; Garikapati K; Kuchipudi A; Cheema G; Elbatta M; Alirhayim Z; Khalid F
Am J Cardiol; 2014 Feb; 113(4):662-8. PubMed ID: 24355310
[TBL] [Abstract][Full Text] [Related]
2. Impact of restarting warfarin therapy in renal disease anticoagulated patients with gastrointestinal hemorrhage.
Khalid F; Qureshi W; Qureshi S; Alirhayim Z; Garikapati K; Patsias I
Ren Fail; 2013 Oct; 35(9):1228-35. PubMed ID: 23902367
[TBL] [Abstract][Full Text] [Related]
3. The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study.
Sengupta N; Feuerstein JD; Patwardhan VR; Tapper EB; Ketwaroo GA; Thaker AM; Leffler DA
Am J Gastroenterol; 2015 Feb; 110(2):328-35. PubMed ID: 25512338
[TBL] [Abstract][Full Text] [Related]
4. Restarting Warfarin vs Direct Oral Anticoagulants After Major Gastrointestinal Bleeding and Associated Outcomes in Atrial Fibrillation: A Cohort Study.
Tapaskar N; Ham SA; Micic D; Sengupta N
Clin Gastroenterol Hepatol; 2022 Feb; 20(2):381-389.e9. PubMed ID: 33227428
[TBL] [Abstract][Full Text] [Related]
5. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding.
Witt DM; Delate T; Garcia DA; Clark NP; Hylek EM; Ageno W; Dentali F; Crowther MA
Arch Intern Med; 2012 Oct; 172(19):1484-91. PubMed ID: 22987143
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction).
Aisenberg J; Chatterjee-Murphy P; Friedman Flack K; Weitz JI; Ruff CT; Nordio F; Mercuri MF; Choi Y; Antman EM; Braunwald E; Giugliano RP
Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e003998. PubMed ID: 29748353
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation.
Hernandez I; Zhang Y; Brooks MM; Chin PK; Saba S
Stroke; 2017 Jan; 48(1):159-166. PubMed ID: 27909200
[TBL] [Abstract][Full Text] [Related]
8. Direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation patients with prior gastrointestinal bleeding: a network meta-analysis of real-world data.
Hu W; Cai H; Zhang J
Eur J Clin Pharmacol; 2022 Jul; 78(7):1057-1067. PubMed ID: 35296907
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal hemorrhage in warfarin anticoagulated patients: incidence, risk factor, management, and outcome.
Chen WC; Chen YH; Hsu PI; Tsay FW; Chan HH; Cheng JS; Lai KH
Biomed Res Int; 2014; 2014():463767. PubMed ID: 24987683
[TBL] [Abstract][Full Text] [Related]
10. Outcomes Associated With Resuming Direct Oral Anticoagulant Therapy Following Admission for a Gastrointestinal Bleed.
Valanejad SM; Davis KA; Nisly SA
Ann Pharmacother; 2020 Oct; 54(10):975-980. PubMed ID: 32141301
[TBL] [Abstract][Full Text] [Related]
11. Restarting of anticoagulation in patients with atrial fibrillation after major bleeding: A meta-analysis.
Zhou Y; Guo Y; Liu D; Feng H; Liu J
J Clin Pharm Ther; 2020 Aug; 45(4):591-601. PubMed ID: 32181518
[TBL] [Abstract][Full Text] [Related]
12. Prior history of falls and risk of outcomes in atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
Banerjee A; Clementy N; Haguenoer K; Fauchier L; Lip GY
Am J Med; 2014 Oct; 127(10):972-8. PubMed ID: 24929021
[TBL] [Abstract][Full Text] [Related]
13. Resuming Anticoagulation Following Hospitalization for Gastrointestinal Bleeding Is Associated with Reduced Thromboembolic Events and Improved Mortality: Results from a Systematic Review and Meta-Analysis.
Tapaskar N; Pang A; Werner DA; Sengupta N
Dig Dis Sci; 2021 Feb; 66(2):554-566. PubMed ID: 32279174
[TBL] [Abstract][Full Text] [Related]
14. Impact of INR monitoring, reversal agent use, heparin bridging, and anticoagulant interruption on rebleeding and thromboembolism in acute gastrointestinal bleeding.
Nagata N; Sakurai T; Moriyasu S; Shimbo T; Okubo H; Watanabe K; Yokoi C; Yanase M; Akiyama J; Uemura N
PLoS One; 2017; 12(9):e0183423. PubMed ID: 28863196
[TBL] [Abstract][Full Text] [Related]
15. Rebleeding vs Thromboembolism After Hospitalization for Gastrointestinal Bleeding in Patients on Direct Oral Anticoagulants.
Sengupta N; Marshall AL; Jones BA; Ham S; Tapper EB
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1893-1900.e2. PubMed ID: 29775794
[TBL] [Abstract][Full Text] [Related]
16. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
[TBL] [Abstract][Full Text] [Related]
17. Warfarin Is Associated With Higher Rates of Upper But Not Lower Gastrointestinal Bleeding Compared with Direct Oral Anticoagulants: A Population-Based Propensity-Weighted Cohort Study.
Ingason AB; Hreinsson JP; Agustsson AS; Lund SH; Rumba E; Palsson DA; Reynisson IE; Gudmundsdottir BR; Onundarson PT; Bjornsson ES
Clin Gastroenterol Hepatol; 2023 Feb; 21(2):347-357.e10. PubMed ID: 35977616
[TBL] [Abstract][Full Text] [Related]
18. Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial.
Flaker G; Lopes RD; Hylek E; Wojdyla DM; Thomas L; Al-Khatib SM; Sullivan RM; Hohnloser SH; Garcia D; Hanna M; Amerena J; Harjola VP; Dorian P; Avezum A; Keltai M; Wallentin L; Granger CB;
J Am Coll Cardiol; 2014 Oct; 64(15):1541-50. PubMed ID: 25301455
[TBL] [Abstract][Full Text] [Related]
19. Management of Oral Anticoagulation Therapy After Gastrointestinal Bleeding: Whether to, When to, and How to Restart an Anticoagulation Therapy.
Kido K; Scalese MJ
Ann Pharmacother; 2017 Nov; 51(11):1000-1007. PubMed ID: 28639882
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML
Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
